After years of research and clinical testing, we have developed non-invasive, accurate blood tests for early detection of cancer. By making cancer prevention routine, we enable everyone to take control of their own health. The more people take our breakthrough blood tests, the more lives we can save. Life over cancer.

Colorectal Cancer Early Detection

Colorectal cancer is among the most preventable cancers when detected early.

This simple blood test can spot cancer even in the pre‑cancerous stage.

Colorectal cancer survival rate is above 90% if caught early1

The risk for colorectal cancer dramatically increases when you are older than 50. Unfortunately, a majority of people are diagnosed after the cancer has already spread. The survival rate for cancer that has metastasized to distant organs is 14%1. CellMax Life CTC blood test is the most affordable blood test for detecting colorectal cancer at its earliest stages.


Easier Screening

The test requires only 1 tube of blood from a routine blood draw.

Higher Compliance

Despite the benefits of regular screening, the rate of CRC in India is rising2. More than 80% of people prefer blood tests to stool-based tests3 or colonoscopy for colorectal cancer screening.

Better Outcomes

This blood test has demonstrated higher accuracy in the detection of pre-cancer than stool-based tests4. Pre-cancerous lesions can be safely removed with a follow-up colonoscopy.

“Screening for colorectal cancer can be life-saving, but Americans still lag behind Federal government screening goals because current screening options can be inconvenient and uncomfortable for patients… a simple, accurate blood test could help increase screening rates, which could ultimately improve detection of colorectal cancers at earlier stages when treatment is most likely to be curative.”

— Nancy Baxter, MD, ASCO Expert in gastrointestinal cancers

How The Test WorksIn 3 simple steps

No lengthy preparation is needed.

Step 1

Purchase a test and schedule an appointment online.

Step 2

At your appointment, one small tube of blood will be drawn.

Step 3

Get results in 1-2 weeks, with expert consultations available.

What We Look For

Our test can detect 1 cancer cell among a billion normal cells.

Cancers shed cells early in development– these cells are called circulating tumor cells, or CTCs. At the pre-cancerous stage, these cells may be as rare as 1 cancer cell among a billion normal cells5. We have developed a patented technology that can find these rare cells in blood. A risk score is calculated based on the presence of these circulating cells in the blood.

Who is this test for?

Every individual over the age of 50 should get screened regularly. This is recommended by all major national medical guidelines including the US Preventative Taskforce, the National Comprehensive Cancer Network, and The American Cancer Society.

What Does the Test Include?

  • A report with a risk score and classification as “low”, “borderline” or “high risk” for colorectal cancer.
  • Recommended follow-ups based on the patient’s risk classification.
  • Review of test results by board-certified physicians.

Why CellMax Life?

  • CellMax Colorectal Cancer Early Detection Test requires only a routine blood draw — no bowel prep, no dietary or medication restrictions, no messy stool sample.
  • More accurate than stool-based tests for the detection of pre-cancerous lesions. These can be easily removed with a follow-up colonoscopy.
  • Studied in and used by thousands of patients worldwide, and endorsed by leading medical experts.

"Screening tests offer some of the greatest potential for getting to zero colorectal cancer deaths… Unlike something such as fecal immunochemical testing, which is not testing specifically for cancer, or colonoscopy, which is quite invasive and detects a lot of things that may never progress to cancer, [the CTC test] offers this potential.”

— Douglas Corley, MD, PhD, of Kaiser Permanente

Early diagnosis through a simple, non-invasive blood test.

—Wall Street Journal


  1. Colorectal Cancer Facts & Figures, 2017-2019 (American Cancer Society)
  2. Current status and future Directions in Colorectal Cancer. Meyer B et al., Indian Surg Oncol
  3. Adler et al, BMC Gastroenterlogy, 2014
  4. Tsai et al, American Society of Clinical Oncology, 2018
  5. West, Jin, JAMA Oncology, June 2015

© 2018 CellMax Life | All Rights Reserved | Terms and Conditions | Privacy Policy